Medrx Co Ltd

NEW
TSE:4586 (Japan)  
円 67 (0%) Aug 28
At Loss
P/B:
2.54
Market Cap:
円 4.44B ($ 27.71M)
Enterprise V:
円 3.29B ($ 20.57M)
Volume:
1.13M
Avg Vol (2M):
2.25M
Trade In:

Business Description

Description
Medrx Co Ltd is a pharmaceutical drug development company founded in January, 2002. The Company engaged in the research and development of pharmaceutical products utilizing the pharmaceutical formulation technology based on ionic liquid transdermal system. The Company develops new pharmaceutical candidates and licenses other companies to produce the pharmaceuticals after clinical trials. Its main products include analgesic patches for anti-inflammatory and pain relief.
Name Current Vs Industry Vs History
Cash-To-Debt
No Debt
Equity-to-Asset
0.91
Interest Coverage
No Debt
Piotroski F-Score
3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score
16.57
Distress
Grey
Safe
Beneish M-Score
-2.7
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI
62.31
9-Day RSI
57.75
14-Day RSI
56.15
3-1 Month Momentum %
1.54
6-1 Month Momentum %
-37.74
12-1 Month Momentum %
-40.54

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio
13.89
Quick Ratio
13.48
Cash Ratio
11.83
Days Inventory
3239.23
Days Sales Outstanding
108.89

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio
-28.1
Name Current Vs Industry Vs History
Gross Margin %
79.1
Operating Margin %
-4640.45
Net Margin %
-4699.77
EBITDA Margin %
-4596.84
FCF Margin %
-8280.26
OCF Margin %
-7574.49
ROE %
-30.01
ROA %
-28.13
ROIC %
-148.28
3-Year ROIIC %
744.42
ROC (Joel Greenblatt) %
-267.94
ROCE %
-29.12

Financials

TSE:4586's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017

Medrx Co Ltd Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil 円) 11.725
EPS (TTM) (円) -9.27
Beta -0.4063
3-Year Sharpe Ratio -0.15
3-Year Sortino Ratio -0.25
Volatility % 79.54
14-Day RSI 56.15
14-Day ATR (円) 3.209673
20-Day SMA (円) 66.25
12-1 Month Momentum % -40.54
52-Week Range (円) 48 - 225
Shares Outstanding (Mil) 66.21

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Medrx Co Ltd Filings

Filing Date Document Date Form
No Filing Data

Medrx Co Ltd Stock Events

Financials Calendars
Event Date Price (円)
No Event Data

Medrx Co Ltd Frequently Asked Questions

What is Medrx Co Ltd(TSE:4586)'s stock price today?
The current price of TSE:4586 is 円67.00. The 52 week high of TSE:4586 is 円225.00 and 52 week low is 円48.00.
When is next earnings date of Medrx Co Ltd(TSE:4586)?
The next earnings date of Medrx Co Ltd(TSE:4586) is .
Does Medrx Co Ltd(TSE:4586) pay dividends? If so, how much?
Medrx Co Ltd(TSE:4586) does not pay dividend.

Press Release

Subject Date
No Press Release

Articles on Medrx Co Ltd

No articles.